Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Amneal Pharmaceuticals, Inc. - Class A Common Stock (NQ:AMRX)

14.16 +0.48 (+3.55%)

Streaming Delayed Price Updated: 2:44 PM EST, Feb 2, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	1,555,727
Open	13.64
Bid (Size)	14.16 (800)
Ask (Size)	14.17 (500)
Prev. Close	13.68
Today's Range	13.64 - 14.29
52wk Range	6.685 - 15.00
Shares Outstanding	1,000
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

3 Cash-Producing Stocks That Concern Us

February 01, 2026

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak...

Via StockStory

3 Healthcare Stocks We Steer Clear Of

January 29, 2026

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have not only realized strong financial performance but also...

Via StockStory

Performance

YTD	+11.9%	+11.9%
1 Month	+11.9%	+11.9%
3 Month	+26.5%	+26.5%
6 Month	+78.0%	+78.0%
1 Year	+73.2%	+73.2%

More News

Amneal Pharmaceuticals Added to S&P SmallCap 600® Index

January 28, 2026

From Amneal Pharmaceuticals LLC

Via GlobeNewswire

Amneal to Report Fourth Quarter and Full Year 2025 Results on February 27, 2026

January 27, 2026

From Amneal Pharmaceuticals LLC

Via GlobeNewswire

Earnings Scheduled For October 30, 2025 ↗

October 30, 2025

Via Benzinga

2 Reasons to Sell AMRX and 1 Stock to Buy Instead

January 25, 2026

Via StockStory

Amneal Announces FDA Approval of Denosumab Biosimilars Referencing Prolia® and XGEVA®

December 22, 2025

From Amneal Pharmaceuticals LLC

Via GlobeNewswire

1 Small-Cap Stock to Target This Week and 2 That Underwhelm

December 17, 2025

Via StockStory

Amneal Receives U.S. FDA Approval for Epinephrine Injection in Single- and Multi-Dose Vials for U.S. Hospitals

December 09, 2025

From Amneal Pharmaceuticals LLC

Via GlobeNewswire

Amneal Announces Positive Interim Phase 4 ELEVATE-PD Results With CREXONT® for Parkinson’s Disease

December 05, 2025

From Amneal Pharmaceuticals LLC

Via GlobeNewswire

3 Healthcare Stocks We’re Skeptical Of

December 02, 2025

Via StockStory

Amneal Receives U.S. FDA Approval for Albuterol Sulfate Inhalation Aerosol

December 02, 2025

From Amneal Pharmaceuticals LLC

Via GlobeNewswire

Amneal to Participate in Upcoming Investor Conferences

December 02, 2025

From Amneal Pharmaceuticals LLC

Via GlobeNewswire

Amneal Announces U.S. FDA Approval of Cyclosporine Ophthalmic Emulsion 0.05%

December 01, 2025

From Amneal Pharmaceuticals LLC

Via GlobeNewswire

Is Amneal Stock a Buy After Investment Firm Westshore Wealth Bought Over 1 Million Shares? ↗

November 28, 2025

Via The Motley Fool

Natera, Amneal, Chemed, The Pennant Group, and HCA Healthcare Shares Are Soaring, What You Need To Know

November 21, 2025

Via StockStory

Amneal EVP Sells $1.6 Million in Shares as Stock Trades Near Multi-Year Highs ↗

November 21, 2025

Via The Motley Fool

Unpacking Q3 Earnings: Amneal (NASDAQ:AMRX) In The Context Of Other Generic Pharmaceuticals Stocks

November 19, 2025

Via StockStory

3 Russell 2000 Stocks with Warning Signs

November 13, 2025

Via StockStory

Amneal Receives U.S. FDA Approval for Iohexol Injection

November 13, 2025

From Amneal Pharmaceuticals LLC

Via GlobeNewswire

3 Stocks Under $50 We Steer Clear Of

November 11, 2025

Via StockStory

Pfizer, Amneal, Jazz Pharmaceuticals, BD, and DaVita Shares Skyrocket, What You Need To Know

November 11, 2025

Via StockStory

3 Value Stocks We Find Risky

November 09, 2025

Via StockStory

Why Amneal (AMRX) Stock Is Up Today

October 31, 2025

Via StockStory

Amneal Pharmaceuticals Inc (NASDAQ:AMRX) Q3 2025 Earnings: EPS Beats Estimates, Stock Surges on Raised Guidance ↗

October 30, 2025

Via Chartmill

Frequently Asked Questions

Is Amneal Pharmaceuticals, Inc. - Class A Common Stock publicly traded?

Yes, Amneal Pharmaceuticals, Inc. - Class A Common Stock is publicly traded.

What exchange does Amneal Pharmaceuticals, Inc. - Class A Common Stock trade on?

Amneal Pharmaceuticals, Inc. - Class A Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Amneal Pharmaceuticals, Inc. - Class A Common Stock?

The ticker symbol for Amneal Pharmaceuticals, Inc. - Class A Common Stock is AMRX on the Nasdaq Stock Market

What is the current price of Amneal Pharmaceuticals, Inc. - Class A Common Stock?

The current price of Amneal Pharmaceuticals, Inc. - Class A Common Stock is 14.16

When was Amneal Pharmaceuticals, Inc. - Class A Common Stock last traded?

The last trade of Amneal Pharmaceuticals, Inc. - Class A Common Stock was at 02/02/26 02:44 PM ET

What is the market capitalization of Amneal Pharmaceuticals, Inc. - Class A Common Stock?

The market capitalization of Amneal Pharmaceuticals, Inc. - Class A Common Stock is 14.16K

How many shares of Amneal Pharmaceuticals, Inc. - Class A Common Stock are outstanding?

Amneal Pharmaceuticals, Inc. - Class A Common Stock has 14K shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.